Gene · 1491
Papers3,417
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,417
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exogenous H2S Attenuates Hypertension by Regulating Renin Exocytosis under Hyperglycaemic and Hyperlipidaemic Conditions. | Int J Mol Sci | 2023 | 36675205 | PubTator, text mining | PubMed |
| The Human Mercaptopyruvate Sulfurtransferase TUM1 Is Involved in Moco Biosynthesis, Cytosolic tRNA Thiolation and Cellular Bioenergetics in Human Embryonic Kidney Cells. | Biomolecules | 2023 | 36671528 | PubTator, text mining | PubMed |
| Dynamic Metabolic and Transcriptional Responses of Proteasome-Inhibited Neurons. | Antioxidants (Basel) | 2023 | 36671027 | PubTator, text mining | PubMed |
| Oxidants and Antioxidants in the Redox Biochemistry of Human Red Blood Cells. | ACS Omega | 2023 | 36643550 | PubTator, text mining | PubMed |
| Personalized redox medicine in inflammatory bowel diseases: an emerging role for HIF-1α and NRF2 as therapeutic targets. | Redox Biol | 2023 | 36634466 | PubTator, text mining | PubMed |
| Implications of hydrogen sulfide in colorectal cancer: Mechanistic insights and diagnostic and therapeutic strategies. | Redox Biol | 2023 | 36630819 | PubTator, text mining | PubMed |
| Enzyme-independent catabolism of cysteine with pyridoxal-5'-phosphate. | Sci Rep | 2023 | 36609609 | PubTator, text mining | PubMed |
Gene's expression underpinning the divergent predictive value of [18F]F-fluorodeoxyglucose and prostate-specific membrane antigen positron emission tomography in primary prostate cancer: a bioinformatic and experimental study. | J Transl Med | 2023 | 36600265 | PubTator, text mining | PubMed |
| Golgi Stress Response: New Insights into the Pathogenesis and Therapeutic Targets of Human Diseases. | Mol Cells | 2023 | 36574967 | PubTator, text mining | PubMed |
| Folic acid attenuates chronic visceral pain by reducing clostridiales abundance and hydrogen sulfide production. | Mol Pain | 2023 | 36550612 | PubTator, text mining | PubMed |
| Hydrogen sulfide as a neuromodulator of the vascular tone. | Eur J Pharmacol | 2023 | 36549499 | PubTator, text mining | PubMed |
| Hydrogen sulfide in the experimental models of arterial hypertension. | Biochem Pharmacol | 2023 | 36528069 | PubTator, text mining | PubMed |
| ANRIL overexpression globally induces expression and alternative splicing of genes involved in inflammation in HUVECs. | Mol Med Rep | 2023 | 36524379 | PubTator, text mining | PubMed |
| Hydrogen Sulfide Attenuates Lipopolysaccharide-Induced Inflammation via the P-glycoprotein and NF-κB Pathway in Astrocytes. | Neurochem Res | 2023 | 36482035 | PubTator, text mining | PubMed |
| Role of hydrogen sulphide in physiological and pathological angiogenesis. | Cell Prolif | 2023 | 36478328 | PubTator, text mining | PubMed |
| ERα/ERβ-directed CBS transcription mediates E2β-stimulated hUAEC H2S production. | J Mol Endocrinol | 2023 | 36476832 | PubTator, text mining | PubMed |
| Sulfide:quinone oxidoreductase ameliorates neurodegeneration in a murine model of Parkinson's disease. | Redox Biol | 2023 | 36470130 | PubTator, text mining | PubMed |
| Recent therapeutic approaches to cystathionine beta-synthase-deficient homocystinuria. | Br J Pharmacol | 2023 | 36417581 | PubTator, text mining | PubMed |
| H2S contributed from CSE during cellular senescence suppresses inflammation and nitrosative stress. | Biochim Biophys Acta Mol Cell Res | 2023 | 36372112 | PubTator, text mining | PubMed |
| CTH G1208T and MTHFR A1298C polymorphisms are associated with a higher risk of a first myocardial infarction with fatal outcome among women. | Drug Metab Pers Ther | 2023 | 36279151 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1491/papers?page=21